CRBU vs ECL · rev $10.0M vs P/E 35, rev $4.01B
Caribou Biosciences Inc (CRBU) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CRBU revenue for 2024-12-31 was $10.0M. Net income was -$149.1M. Revenue was down 71.0% from 2023-12-31 to 2024-12-31. CRBU currently screens at market cap $190.4M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CRBU currently screens at market cap $190.4M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CRBU and ECL stock pages for the full models.
Not investment advice.